Treatment Patterns and Relapses Among Newly Treated Multiple Sclerosis Patients From a Retrospective Claims Analysis

Daniel Kantor,Rina Mehta,Corey Pelletier,Marc Tian,Virginia Noxon,Barbara H. Johnson,Machaon Bonafede

Clinical Therapeutics（2020）

Cited 3|Views8

No score

Abstract

•Nonpersistence in multiple sclerosis (MS) may lead to relapse and disability.•Over a third of MS patients were nonpersistent with disease-modifying therapy (DMT).•Over one fifth of patients had a relapse within 1 year of initiating a DMT.•Persistence was higher and relapse rates lower with oral vs injectable DMTs.

Translated text

Key words

disease-modifying therapy,drug administration routes,insurance claim review,persistence

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined